EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serratia sp. traits distinguish the lung microbiome of patients with tuberculosis and non-tuberculous mycobacterial lung diseases

Meriem Belheouane iD, Barbara Kalsdorf, Stefan Niemann, Karoline I Gaede, Christoph Lange, Jan Heyckendorf, Matthias Merker iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0325362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Meriem Belheouane und 6 weiteren Autor:innen. Beteiligte Einrichtung: Evolution of the Resistome, Research Center Borstel, Borstel, Germany. Hauptthemen laut MEDLINE: Microbiota, Lung, Serratia, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Excellence Cluster for Precision Medicine in Chronic inflammation, German Center of Infection Research, Leibniz Science Campus Evolutionary Medicine of the LUNG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathogenic mycobacteria, such as Mycobacterium tuberculosis complex (Mtbc), and non-tuberculous mycobacteria (NTMs) can cause severe chronic pulmonary infections. However, not all infected patients develop active disease, and it remains unclear whether key lung microbiome taxa play a role in the pathogenesis of tuberculosis (TB) and NTM lung diseases (LD). Here, we aim to further define the lung microbiome composition in TB, and NTM-LD prior to the initiation of therapy. Study design We employed 16S rRNA amplicon sequencing to characterize the baseline microbiome in bronchoalveolar lavage fluid (BALF) from patients diagnosed with TB (n = 23), NTM-LD (n = 19), or non-infectious inflammatory disease (n = 4). We applied depletion of human cells, removal of extracellular DNA, implementation of a decontamination strategy, and exploratory whole-metagenome sequencing (WMS) of selected specimens.

Results

Genera Serratia and unclassified Yersiniaceae dominated the lung microbiome of most patients with a mean relative abundance of >15% and >70%, respectively. However, at the sub-genus level, as determined by amplicon sequence variants (ASVs), TB-patients exhibited increased community diversity, and distinct signatures of ASV_7, ASV_21 abundances which resulted in a significant association with disease state. Exploratory WMS, and ASV similarity analyses suggested the presence of Serratia liquefaciens , Serratia grimesii , Serratia myotis and/or Serratia quinivorans in TB and NTM-LD patients.

Conclusions

The lung microbiome of TB-patients harbored a distinct, and heterogenous structure, with specific occurrences of certain Serratia traits. Some of these traits may play a role in understanding the microbial interactions in the lung microbiome of patients infected with Mtbc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrobiotaLungSerratiaMycobacterium Infections, NontuberculousTuberculosis, PulmonaryLung DiseasesHumansMaleMiddle AgedRNA, Ribosomal, 16SFemaleAdultBronchoalveolar Lavage FluidAgedNontuberculous Mycobacteria

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Evolution of the Resistome, Research Center Borstel, Borstel, Germany.
  • Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
  • Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
  • German Center for Infection Research (DZIF), Partner site Hamburg, Lübeck, Borstel, Riems, Borstel, Germany.
  • BioMaterialBank Nord, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
  • German Centre for Lung Research (DZL), Airway Research Centre North (ARCN), Großhansdorf, Germany.

ORCID-Profile: Meriem Belheouane, Matthias Merker

Förderung

  • German Excellence Cluster for Precision Medicine in Chronic inflammation
  • German Center of Infection Research
  • Leibniz Science Campus Evolutionary Medicine of the LUNG
  • German Center for Lung Research

Zitieren

APA

Belheouane, M., Kalsdorf, B., Niemann, S., Gaede, K. I., Lange, C., Heyckendorf, J., & Merker, M. (2025). Serratia sp. traits distinguish the lung microbiome of patients with tuberculosis and non-tuberculous mycobacterial lung diseases. PLOS One. https://doi.org/10.1371/journal.pone.0325362

Vancouver

Belheouane M, Kalsdorf B, Niemann S, Gaede KI, Lange C, Heyckendorf J, et al. Serratia sp. traits distinguish the lung microbiome of patients with tuberculosis and non-tuberculous mycobacterial lung diseases. PLOS One. 2025. doi:10.1371/journal.pone.0325362

BibTeX
@article{Belheouane2025,
  author = {Belheouane, Meriem and Kalsdorf, Barbara and Niemann, Stefan and Gaede, Karoline I and Lange, Christoph and Heyckendorf, Jan and Merker, Matthias},
  title = {Serratia sp. traits distinguish the lung microbiome of patients with tuberculosis and non-tuberculous mycobacterial lung diseases},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325362}
}
Kostenlos starten →